
Sign up to save your podcasts
Or


Join ESPN’s Stephania Bell, PT, OCS Emeritus, CSCS, as she sits down at AOSSM 2025 with Dr. Scott Rodeo — Professor of Orthopedic Surgery and Vice Chair of Research at Hospital for Special Surgery, Director of the HSS Center for Regenerative Medicine, and Head Team Physician for the New York Giants.
In this conversation, Dr. Rodeo breaks down the rapidly evolving world of orthobiologics, including what current evidence supports, where the biggest gaps in knowledge still exist, and how clinicians can navigate PRP, stem cell therapies, and patient expectations in today’s sports medicine landscape.
Physical therapists will learn about:
- The strongest indications for PRP in athletic populations
- What platelet-poor plasma (PPP) is and why it may benefit muscle injuries
- The realities and limitations of “stem cell” therapies in 2025
- Key regulatory restrictions in the United States vs. overseas practices
- How to counsel athletes exploring medical tourism for regenerative treatments
- Emerging cellular technologies and where the science is heading
Target Audience:
Orthopedic physical therapists, sports physical therapists, athletic trainers, sports medicine surgeons, sports performance clinicians, strength and conditioning coaches, rehab directors, PT students, and sports science professionals.
By APTA Orthopedics4.5
22 ratings
Join ESPN’s Stephania Bell, PT, OCS Emeritus, CSCS, as she sits down at AOSSM 2025 with Dr. Scott Rodeo — Professor of Orthopedic Surgery and Vice Chair of Research at Hospital for Special Surgery, Director of the HSS Center for Regenerative Medicine, and Head Team Physician for the New York Giants.
In this conversation, Dr. Rodeo breaks down the rapidly evolving world of orthobiologics, including what current evidence supports, where the biggest gaps in knowledge still exist, and how clinicians can navigate PRP, stem cell therapies, and patient expectations in today’s sports medicine landscape.
Physical therapists will learn about:
- The strongest indications for PRP in athletic populations
- What platelet-poor plasma (PPP) is and why it may benefit muscle injuries
- The realities and limitations of “stem cell” therapies in 2025
- Key regulatory restrictions in the United States vs. overseas practices
- How to counsel athletes exploring medical tourism for regenerative treatments
- Emerging cellular technologies and where the science is heading
Target Audience:
Orthopedic physical therapists, sports physical therapists, athletic trainers, sports medicine surgeons, sports performance clinicians, strength and conditioning coaches, rehab directors, PT students, and sports science professionals.

368 Listeners

1,193 Listeners

56,702 Listeners

8,497 Listeners

8,554 Listeners

323 Listeners

67 Listeners

27,455 Listeners

1,126 Listeners

90 Listeners

81 Listeners

34 Listeners

29,245 Listeners

20,620 Listeners

1,193 Listeners